Venus Concept Inc. (NASDAQ:VERO – Get Free Report) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,450,000 shares, a growth of 1,956.7% from the October 15th total of 70,500 shares. Approximately 35.1% of the shares of the company are short sold. Based on an average daily volume of 1,690,000 shares, the days-to-cover ratio is presently 0.9 days.
Insider Activity
In other news, major shareholder Michael Willingham Masters sold 71,368 shares of the firm’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $0.64, for a total transaction of $45,675.52. Following the completion of the sale, the insider now directly owns 22,383 shares of the company’s stock, valued at $14,325.12. This trade represents a 76.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 57.98% of the company’s stock.
Institutional Investors Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its stake in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 666,702 shares of the company’s stock after buying an additional 333,366 shares during the period. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. 87.41% of the stock is owned by hedge funds and other institutional investors.
Venus Concept Stock Up 4.1 %
Venus Concept (NASDAQ:VERO – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($1.39) earnings per share (EPS) for the quarter. The firm had revenue of $16.58 million during the quarter. Analysts anticipate that Venus Concept will post -6.37 EPS for the current fiscal year.
Venus Concept Company Profile
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
See Also
- Five stocks we like better than Venus Concept
- 3 REITs to Buy and Hold for the Long Term
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- 3 Fintech Stocks With Good 2021 Prospects
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.